Makeup and SFX artist Jo Steel demonstrates an easy cel-shading makeup tutorial. Libya’s top general killed — here’s what we ...

To help people along their paths, I’m honored to have led the creation of Concordia College’s new Center for Entrepreneurial ...

Major, fresh-for-2025 updates on the Rivian R1S SUV and R1T pickup truck dropped this week. Open our comprehensive first-drive review in another tab to check out later if you haven’t! One of the ...

BHPian subramanyam84 recently shared this with other enthusiasts:37000+ km observation on my Mahindra XUV300 TGDiThe check engine light came up one fine day on the way to work. Odo: 36000km. Jan 2023 ...

Autolus will evaluate Cellares’ fully automated, high-throughput manufacturing platform in preparation for expansion into new indicationsSOUTH SAN FRANCISCO, Calif. and LONDON, Jan. 06, 2026 (GLOBE ...

Section 9 Interactive studio co-founders, Marcus and Mattias Otvall, discuss the inspirations behind the horror adventure ...

Data presented at ASH 2025 suggest earlier-line use of cilta-cel leads to better outcomes in multiple myeloma because patients have fitter immune systems and less exhausted T cells, improving CAR T ...

ADNEC Group’s diverse business clusters span Venues, Events, F&B, Services, Tourism and Media. The Group operates the ADNEC ...

Cellectis (the 'Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its ...

H 2026 Catalyst Stack Anticipated to Validate Scalable, Off-the-Shelf CAR T in Oncology and Autoimmune DiseaseInterim Futility Analysis of MRD Clearance from the Pivotal Phase 2 ALPHA3 Trial with ...

During a live event, Matthew Lunning, DO, interpreted long-term outcomes of the ZUMA-7 and TRANSFORM trials.

Johnson & Johnson’s Janssen unit has filed for approval of its multiple myeloma CAR-T ciltacabtagene autoleucel in Europe, chasing after a rival therapy from Bristol-Myers Squibb. The BCMA-targeting ...